Colgate-Palmolive stock downgraded by TD Cowen on inflation concerns

TD Cowen downgraded Colgate-Palmolive to Hold and cut its price target to $85 (from $96); the stock trades at $85.73. TD Cowen trimmed EPS expectations to 4.0% growth for 2026 (consensus 5%) and 4.5% for 2027 (consensus 7%), citing higher costs for oil-based inputs and tallow (tallow up ~40% YoY on CME) and forecasting inflationary pressure through Q3 2026–Q2 2027. Offsetting factors: Q4 EPS beat $0.95 vs $0.91 expected, Deutsche Bank upgraded to Buy with a $98 PT, UBS reiterated Buy with a $93 PT, and Colgate raised its quarterly dividend to $0.53 ($2.12 annualized).

Analysis

A raw-material shock centered on resin and animal-fat inputs shifts the competitive map: manufacturers with long-term bilateral resin contracts and integrated supply chains will defend margins, while mid-sized consumer names face a squeeze that translates into higher promotional intensity and SKU rationalization. Retailers will capture some of the margin relief window as brands scramble to maintain volumes, so expect private-label penetration to accelerate in the next 3-9 months and to pressure branded share in developed markets.

The most important catalyst to watch is the cadence of input-cost normalization versus the lag on price realization. If resin/tallow prices roll over within a quarter, companies that delayed promotions will re-price and recover margin within two to three quarters; if elevated costs persist beyond six months, working-capital stress and margin dilution will force accelerations in productivity programs and potential portfolio pruning. Currency moves in emerging markets are a wildcard — material devaluation would blunt local pricing power and turn an inflation hedge into an earnings headwind.

Consensus skepticism about resilience is a useful entry signal if one believes management levers — mix management, trade investment reallocation, and small pack-size premiumization — remain underpriced. The most actionable relative trades are long commodity/chemical suppliers that benefit from higher resin/tallow spreads and short mid-cap branded consumer names lacking scale; hedged option structures on staples can monetize limited downside while keeping upside optionality if pricing power proves sticky.

Key Decisions for Investors

• Pair trade (3–9 months): Short CL / Long PG — enter on a relative weakness signal (e.g., two consecutive sessions of CL underperformance vs XLP). Target 6–9% relative outperformance in 3–9 months. Size to 2–3% net portfolio exposure; place a stop if relative underperformance breaches 3% adverse move.
• Curve trade (3–12 months): Long LYB or EMN to capture higher resin spreads — initiate 6–12% position if resin futures remain elevated. Target 15–25% upside if commodity spreads persist; risk is 10–12% downside if resin collapses quickly—use a 20% trailing stop or pair with a short chemical ETF to neutralize broad market beta.
• Options hedge (4–6 months): Buy a CL put spread (buy 6-month 7% OTM put, sell 6-month 14% OTM put) funded by selling a nearer-OTM call 10–12% above spot. This structure caps cost, limits downside to defined range, and leaves upside participation if input fears abate. Keep notional ≤2% portfolio.
• Event trigger (days–weeks): Monitor quarterly trading updates and resin/tallow futures; if management signals incremental US trade investment or accelerated productivity cuts, rotate half of the CL short into select EM-focused staples with faster price pass-through (size = 1–2% portfolio, horizon 6–12 months).